During the #BHHSummit on October 29, one of the panel discussions will discuss “Digital Therapeutics – The new drugs?”.
Backed by clinical trials, DTx are proving to be effective therapeutic solutions, used either on their own or coupled with drugs. They can collect large amounts of Real World Data, useful to develop or personalize drugs and treatments. They enable to serve more patients, at a lower cost, from anywhere, 24/7… which resulted useful in the pandemic and reinforced even more the value of DTx for the healthcare systems. Where are we in terms of implementation? What does a successful partnership look like for a DTx company? What can we learn from the German regulation and how can we make it happen in other countries?
Experts will join the discussion about “Digital Therapeutics – The new drugs?”:
- Celine Ulmann, Head of R&D Digital at Almirall
- Jonas Duss, Cofounder & US CEO at Kaia Health
- Edward Kliphuis, Partner at Amadeus Capital Partners
- Dr. Guido Senatore, Country Medical Director Spain at Bayer
The session will take place in the morning and it will be moderated by Pascal Lardier, Vice President, Events & Media Content – International at HIMSS.
Don’t miss it on October 29 and reserve your free ticket to the #BHHSummit here!